Hodgkin lymphoma-like posttransplantation lymphoproliferative disorder

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 4, 2006, Pages 558-560

  Semakula, Barbara ^a   Rittenbach, Jon V ^a   Wang, Jun ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB;

B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MEDICAL LITERATURE; MOLECULAR GENETICS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PROGNOSIS; SHORT SURVEY; WORLD HEALTH ORGANIZATION; B LYMPHOCYTE; IMMUNE DEFICIENCY; PATHOLOGY; REVIEW;

B-LYMPHOCYTES; HODGKIN DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; ORGAN TRANSPLANTATION;

EID: 33645762960     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol. 1988;133:173-192.
2. Midthun DE, McDougall JC, Peters SG, Scott JP. Medical management and complications in the lung transplant recipient. Mayo Clin Proc. 1997;175-184.
3. Harris NL, Swerdlow SH, Frizzera G, Knowles DM. Post-transplant lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:264-269. World Health Organization Classification of Tumours.
4. Chetty R, Biddolph S, Gatter K. An immunohistochemical analysis of Reed Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin's disease and Reed-Sternberg-like cells in non-Hodgkin's lymphomas and reactive conditions. Hum Pathol. 1997;28:493-498.
5. Penn I. De novo malignancies in pediatric organ transplant recipients. Pediatr Transplant. 1998;2:56-63.
6. Ranganathan S, Webber S, Ahuja S, Jaffe R. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma? Pediatr Dev Pathol. 2004;7:348-360.
7. Rowlings PA, Curtis RE, Passweg JR, et al. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol. 1999;17:3122-3127.
8. Sterling WA, Wu LYF, Dowling EA. Hodgkin's disease in a renal transplant recipient. Transplantation. 1974;17:315-317.
9. Cerilli J, Rynasiewicz JJ, Lemos LB, Rothermel WS Jr. Hodgkin's disease in human renal transplantation. Am J Surg Pathol. 1977;133:182-184.
10. Doyle TJ, Venkatachalam KK, Maeda K, Saees SM, Tilchen EJ. Hodgkin's disease in renal transplant recipients. Cancer. 1983;51:245-247.
11. Oldhafer KJ, Bunzendahl H, Frei U, Kemnitz J, Vogt P, Pichlmayr R. Primary Hodgkin's lymphoma: an unusual cause of graft dysfunction after kidney transplantation. Am J Med. 1989;87:218-220.
12. Nalesnik M, Randhawa P, Demetris AJ, Casavilla A, Fung J, Locker J. Lymphoma resembling Hodgkin's disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer. 1993;72:2568-2573.
13. Garnier JL, Lebranchu Y, Dantal J, et al. Hodgkin's disease after transplantation. Transplantation. 1996;61:71-76.
14. Goyal RK, McEvoy L, Wilson DB. Hodgkin's disease after renal transplantation in childhood. J Pediatr Hematol Oncol. 1996;18:392-395.
15. Bierman PJ, Vose JM, Langnas AN, et al. Hodgkin's disease following solid organ transplantation. Ann Oncol. 1996;7:265-270.
16. Smets F, Vajro P, Cornu G, Reding R, Otte JB, Sokal E. Indications and results of chemotherapy in children with post-transplant lymphoproliferative disease after liver transplantation. Transplantation. 2000;69:982-985.
17. Younes SI, McDiarmid SV, Martin MG, et al. The effect of immunosuppression on post-transplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation. 2000;70:94-99.
18. Hayashi RJ, Kraus MD, Patel AL, et al. Posttransplant lymphoproliferative disease in children: correlation of histology to clinical behavior. J Pediatr Hematol Oncol. 2001;23:14-18.
19. Dharnidharka VR, Douglas VK, Hunger SP, Fennell RS. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transplant. 2004;8:87-90.
20. Pitman SD, Huang Q, Zuppan CW, et al. Hodgkin lymphoma-like post-transplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically. Am J Surg Pathol. 2006. In press.
21. Kanzler H, Kuppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184:1495-1505.
22. Brauninger A, Hansmann ML, Strickler JG. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med. 1999;340:1239-1247.
23. Timms JM, Bell A, Flavell JR, et al. Target cells of Epstein-Barr virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma. Lancet. 2003;361:217-223.
24. Nalesnik MA. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovasc Surg. 1996;8:139-148.
25. Verschuuren EAM, Stevens SJC, van Inhofe GW, et al. Treatment of post-transplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation. 2002;73:100-104.
26. Pham PT, Wilkinson AH, Gritsch HA, et al. Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with post-transplant lymphoproliferative disease. Transplant Proc. 2002;34:1178-1181.